2021
DOI: 10.1097/inf.0000000000003267
|View full text |Cite
|
Sign up to set email alerts
|

Antibiotic Therapy of an Infant With a Brevibacterium casei Ventriculoperitoneal Shunt Infection

Abstract: We describe a newborn infant with hydrocephalus and a ventriculoperitoneal shunt infection caused by Brevibacterium casei. Essential for correct diagnosis was rapid species identification by matrix-assisted laser desorption/ionization time-of-flight, after initial report of coryneform bacteria. The patient responded well to vancomycin and rifampicin for 15 days. The shunt was not removed. Repeated cerebrospinal fluid cultures up to 4 months after therapy remained negative.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 8 publications
0
0
0
Order By: Relevance
“…B. casei is a glutin-degrading Gram-positive bacterium in the human intestine [47]. It is a rare opportunistic pathogen in humans [48] that can be treated by vancomycin [49], but some of its strains are vancomycin-resistant [50].…”
Section: Discussionmentioning
confidence: 99%
“…B. casei is a glutin-degrading Gram-positive bacterium in the human intestine [47]. It is a rare opportunistic pathogen in humans [48] that can be treated by vancomycin [49], but some of its strains are vancomycin-resistant [50].…”
Section: Discussionmentioning
confidence: 99%